Target intelligence / Profile preview

TXN2 pseudogene 1 (TXN2P1)

Target
TXN2P1
Molecular classification
Pseudogene, non-coding RNA
01

Overview

TXN2 pseudogene 1 (TXN2P1) is a genomic DNA sequence homologous to the protein-coding TXN2 (thioredoxin 2) gene but lacks the ability to encode a functional protein. Pseudogenes may arise from gene duplication or retrotransposition events and typically accumulate mutations that prevent protein expression. While some pseudogenes can be transcribed into non-coding RNAs, there is no evidence that TXN2 pseudogene 1 plays a functional biological or disease role or serves as a therapeutic target. Information about the protein-coding TXN2 gene is not applicable to the pseudogene. "TXN2 pseudogene 1" is not to be confused with the functional gene "Thioredoxin 2 (TXN2)". Therapeutic interest pertains to TXN2, not its pseudogenes. Current genomic and functional databases do not identify TXN2P1 as a validated therapeutic or biomarker target; its only role is as a marker of genomic architecture. For TXN2 pseudogene 1, it should generally be considered a non-target, non-functional locus.

Other names
thioredoxin 2 pseudogene 1
02

Mechanism of action

None, as there is no protein or target to modulate

03

Biological functions

None establishedpseudogenes typically do not have protein-coding biological functions
04

Disease associations

No direct disease associationsthe functional TXN2 gene is related to oxidative stress and some pathologies, but not the pseudogene TXN2P1
05

Safety considerations

None described, as TXN2P1 is not an expressed or actionable target
06

Biomarkers

None specific to TXN2P1pseudogenes can sometimes serve as RNA expression biomarkers in cancer, but no evidence for TXN2P1 specifically was found

Beyond the preview

Go deeper on TXN2 pseudogene 1 (TXN2P1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on TXN2 pseudogene 1 (TXN2P1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call